DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidLVADVA-ECMOheart transplantadvanced heart failurebridge strategy

Mechanical circulatory support and heart transplantation

Essential points for quick revision.

!
Escalate

Refractory cardiogenic shock, recurrent arrest/VT-VF, low-flow LVAD alarm with hypoperfusion, suspected pump thrombosis or major LVAD bleeding requires immediate resuscitation and contact with the implanting/advanced-HF centre; device patients may have no palpable pulse despite circulation.

Synopsis

Recognise advanced-heart-failure referral triggers, match temporary or durable support to a bridge goal and understand the UK specialist pathway to transplantation.

  • Refer advanced HF early: recurrent admission, escalating diuretic, prior inotrope, NYHA III–IV despite therapy, low BP, worsening renal/liver function, severe RV dysfunction or ventricular arrhythmia are red flags.
  • Every device needs a bridge goal: recovery, intervention, decision, candidacy, transplantation or long-term support; reassess that goal daily in temporary MCS.
  • An intra-aortic balloon pump modestly augments coronary perfusion; a microaxial LV pump unloads the LV; VA-ECMO supplies circulation plus gas exchange but may increase LV afterload; an RVAD supports isolated RV failure.

Key red flags

Refractory shock

Rising lactate, escalating vasoactive support and multi-organ injury despite cause treatment may require temporary MCS before irreversibility.

Investigation priorities

01
Advanced-HF assessment: echo, ECG, natriuretic peptide, renal/liver/haematology and functional testingFirst step

Confirm severity, RV function, reversibility and referral urgency.

Management branches

First-lineEarly advanced-HF referral

One or more advanced-HF red flags despite guideline-directed therapy

  1. Refer to an advanced-HF/transplant centre while optimising four-class therapy, rhythm, CRT/ICD, valve/coronary disease, congestion, iron and rehabilitation.
  2. Send the trajectory: admissions, inotrope/diuretic exposure, BP, renal/liver function, RV/LV imaging, arrhythmia and functional status.
Open full textbook Answer 2 questionsCardiology check
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom